Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker.
Barbu CG, Arsene AL, Florea S, Albu A, Sirbu A, Martin S, Nicolae AC, Burcea-Dragomiroiu GTA, Popa DE, Velescu BS, Dumitrescu IB, Mitrea N, Draganescu D, Lupuliasa D, Spandidos DA, Tsatsakis AM, Dragoi CM, Fica S.
Barbu CG, et al.
Mol Med Rep. 2017 Nov;16(5):6059-6067. doi: 10.3892/mmr.2017.7376. Epub 2017 Aug 28.
Mol Med Rep. 2017.
PMID: 28849089
Free PMC article.
Clinical Trial.